Drugging RNA was once considered impossible. Now Big Pharma can’t get enough of it

Once considered impossible, Big Pharma has warmed up to the idea of drugging RNA over the last few years, inking platform deals with companies like Arrakis and Skyhawk. Now, Sanofi and Novartis are reaching a little deeper into their wallets for one of the earliest players in this arena.

Expansion...

Click to view original post